Member of the Board of Directors
John H. Powers III, M.D., F.A.C.P., F.I.D.S.A.
Dr. Powers is a physician/investigator on faculty as a Professor of Clinical Medicine at the George Washington University School of Medicine. Prior to his current position Dr. Powers was the Lead Medical Officer for Antimicrobial Drug Development and Resistance Initiatives in the Office of Antimicrobial Products, Center for Drug Evaluation and Research, at the US Food and Drug Administration where he was responsible for issues related to clinical trials and policy in antimicrobial research. Dr Powers also worked in the Office of Medical Policy during his time at FDA. Dr. Powers was a co-chair for the Inter-Agency Task for on Antimicrobial Resistance of 11 federal agencies responsible for implementing the Public Health Action Plan to Combat Antimicrobial Resistance, and a member of the WHO Advisory Group on Integrate Surveillance of Antimicrobial Resistance. Prior to joining the FDA, Dr. Powers was assistant professor in the Division of Infectious Diseases at the University of Maryland School of Medicine and he still is on the faculty. Dr. Powers research is in the development and evaluation of patient-centric outcomes for clinical trials and advancing research methodologies in general. Dr. Powers also actively sees patients and attends on the infectious diseases service.
Dr. Powers received his bachelor’s degree and graduated magna cum laude from the University of Pennsylvania. He received his medical degree and residency training from Temple University School of Medicine, where he also served as Chief Resident. He completed his infectious diseases training at the University of Virginia School of Medicine. Dr Powers is board certified in internal medicine and infectious diseases.
Dr. Powers has been an investigator on over 60 clinical trials. He is a fellow in the American College of Physicians and the Infectious Diseases Society of America, Chair of the Clinical Outcomes Assessments (COA) Task Force for the International Society of Pharmacoeconomics and Outcomes Research (ISPOR), and a member of the Veteran’s Administration Clinical Study Scientific Evaluation Committee (CSSEC). Dr. Powers has particular expertise in the design, conduct and analysis of clinical trials. He has authored several book chapters and publications on clinical trial design and outcomes assessments. While at FDA he helped formulate the FDA guidance on patient reported outcomes and helped train FDA reviewers in its implementation. He has won several awards for teaching medical students, residents and fellows, and most recently was one of seven nominees for the 2008 Distinguished Clinical Teacher Award by the National Institutes of Health Fellows Committee. He was a recipient of the NIH Directors Award in 2010. In addition, he is on the editorial board of Antimicrobial Agents and Chemotherapy and the British Medical Journal, as well as a reviewer for several other scientific journals. Dr. Powers’ area of research is on clinical research methodologies with particular interest in outcome assessments and endpoints and patient engagement in clinical trials.
John H. Powers III
Meet our board
Click on a member of the HLM Board to learn more about them.